Cancer is the second leading cause of deaths worldwide. In 2015, 8.8 million people died from cancer. Globally, nearly one-sixth of deaths are caused by cancer. Gastric cancer, esophageal cancer, and colorectal cancer are among the top 6 of malignant tumors. Developing new drugs for cancers of the digestive system is challenging, and existing drugs and targets are limited, resulting in a large number of unmet clinical needs.

KH903 is a Class 1 novel biological drug for the treatment of colorectal cancer and tumors of other organs.

*This is in clinical trials